Clinical Trials Logo

Active Juvenile Psoriatic Arthritis clinical trials

View clinical trials related to Active Juvenile Psoriatic Arthritis.

Filter by:
  • None
  • Page 1

NCT ID: NCT04804553 Not yet recruiting - Clinical trials for Active Juvenile Psoriatic Arthritis

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

PEAPOD
Start date: July 27, 2021
Phase: Phase 3
Study type: Interventional

The study will aim to estimate the efficacy of apremilast compared with placebo in the treatment of juvenile psoriatic arthritis (JPsA) in pediatric participants 5 to less than 18 years of age.